Company profile
Alia Therapeutics
Safe and durable gene editing solutions for patients
- Industry
- Biotechnology
- Employees
- 10
- Headquarters
- Trento, Trentino-Alto Adige
- Founded
- 2018
- LinkedIn followers
- 3,359
- Office locations
- 2
Alia Therapeutics company summary
Alia Therapeutics is a company in the Biotechnology industry, headquartered in Trento, Trentino-Alto Adige, founded in 2018. On LinkedIn the company has around 10 employees and 3,359 followers. The company lists 2 office locations.
What technology does Alia Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Alia Therapeutics
Alia Therapeutics is a biotechnology company dedicated to developing next-generation gene editing therapies for Inherited Retinal Diseases, starting with Retinitis Pigmentosa a leading cause of inherited blindness worldwide. IRDs are marked by extreme genetic and clinical heterogeneity, making traditional therapeutic approaches difficult to scale and leaving many patients without viable treatment options. Alia addresses this challenge through a modular, mutation-agnostic approach enabled by its proprietary CRISPR platform. At the core of Alia’s technology are novel, next-generation CRISPR enzymes discovered in-house with superior in vivo editing efficacy and delivered using a single AAV vector, providing advantages in efficiency, manufacturability, and cost. Alia’s platform enables the rapid reprogramming to target multiple disease-causing mutations, expanding the addressable patient population across genetically diverse IRDs. Our mission is to transform the treatment of inherited blindness by delivering scalable, precise, and durable gene editing solutions to patients who need them most.
Where is Alia Therapeutics located?
Alia Therapeutics lists 2 office locations.
Compare companies similar to Alia Therapeutics
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Alia Therapeutics aliatherapeutics.com | Biotechnology | 10 | 2018 | Trento, Trentino-Alto Adige |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about Alia Therapeutics
What does Alia Therapeutics do?
Alia Therapeutics is a biotechnology company dedicated to developing next-generation gene editing therapies for Inherited Retinal Diseases, starting with Retinitis Pigmentosa a leading cause of inherited blindness worldwide. IRDs are marked by extreme genetic and clinical heterogeneity, making traditional therapeutic approaches difficult to scale and leaving many patients without viable treatment options. Alia addresses this challenge through a modular, mutation-agnostic approach enabled by its proprietary CRISPR platform. At the core of Alia’s technology are novel, next-generation CRISPR enzymes discovered in-house with superior in vivo editing efficacy and delivered using a single AAV vector, providing advantages in efficiency, manufacturability, and cost. Alia’s platform enables the rapid reprogramming to target multiple disease-causing mutations, expanding the addressable patient population across genetically diverse IRDs. Our mission is to transform the treatment of inherited blindness by delivering scalable, precise, and durable gene editing solutions to patients who need them most.
How many employees does Alia Therapeutics have?
Alia Therapeutics has around 10 employees on LinkedIn.
Where is Alia Therapeutics headquartered?
Alia Therapeutics is headquartered in Trento, Trentino-Alto Adige.
Where does Alia Therapeutics have offices?
Alia Therapeutics lists 2 office locations, including Trento, Trentino-Alto Adige, IT; Milano, IT, IT.
When was Alia Therapeutics founded?
Alia Therapeutics was founded in 2018.
Build a lead list from companies like Alia Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.